Stay updated on Emixustat in Stargardt Macular Atrophy Clinical Trial
Sign up to get notified when there's something new on the Emixustat in Stargardt Macular Atrophy Clinical Trial page.

Latest updates to the Emixustat in Stargardt Macular Atrophy Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.3.2 is shown instead of v3.3.1; no other visible changes to the study page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoChange DetectedA new note clarifies that publications are auto-filled from PubMed and may not be about the study, and the page revision was updated to v3.3.1. The previous PubMed note and earlier revision label (v3.2.0) were removed.SummaryDifference0.1%

- Check20 days agoChange DetectedA government funding/operating status notice was removed from the page; the study details content itself remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check34 days agoChange DetectedThe new screenshot shows minor layout adjustments and updated timestamps, while the study details, eligibility criteria, locations, enrollment, and primary/secondary outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check63 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference5%

- Check70 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0 indicates a new release; no other content changes are shown.SummaryDifference0.1%

Stay in the know with updates to Emixustat in Stargardt Macular Atrophy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Emixustat in Stargardt Macular Atrophy Clinical Trial page.